PEPTIDE RESEARCH TOPIC

Epithalon Research Peptide

Epithalon is a synthetic tetrapeptide examined in cellular aging and telomere research. Browse its identity, experiments, evidence limitations, and related articles.

TOPIC OVERVIEW

About Epithalon

Identity and names

Epithalon and Epitalon are alternative spellings used for the same tetrapeptide. Epithalamin is a different preparation and its findings cannot automatically be assigned to Epithalon.

Compound type

It is a synthetic four-amino-acid peptide, commonly described as Ala-Glu-Asp-Gly. Salt forms and purity specifications require separate documentation.

Mechanism

Laboratory studies investigate telomerase expression, telomere maintenance, and cellular responses. A telomere change in cultured cells is a surrogate finding.

Research focus and evidence

Published cell-culture work provides a mechanistic basis for further study. It does not establish extended human lifespan, cancer prevention, or an anti-aging treatment.

Regulatory status and limits

The sources linked here do not establish a broadly approved human anti-aging indication. Regulatory assessment and evidence of clinical benefit are separate questions.

Topics covered
  • telomeres and telomerase
  • Epithalon versus Epithalamin
  • cell culture evidence
  • aging claims and limitations
  • identity and formulation
Common names and related terms: Epithalon, Epitalon, Ala-Glu-Asp-Gly
RESEARCH SUMMARY

What Is Epithalon?

LAST VERIFIEDOctober 7, 2026

A 2003 experiment reported telomerase activity and telomere elongation in human fetal fibroblast cultures exposed to Epithalon. These cultured-cell outcomes should not be read as evidence that administering the peptide extends human life. Epithalon telomerase experiment

A later investigation compared normal and cancer-derived cell lines and reported different telomere-related pathways. The distinction reinforces the need to interpret telomere findings in their specific cellular setting rather than as a universal health benefit. Epitalon telomere study

EVIDENCE PROFILE

Epithalon Research Evidence

A concise view of registered clinical research, PubMed-indexed literature, evidence stage, and important limitations.

LAST VERIFIEDOctober 7, 2026
Registered records0
Active studies0
Completed studies0
PubMed records115
Compound typeIt is a synthetic four-amino-acid peptide, commonly described as Ala-Glu-Asp-Gly. Salt forms and purity specifications require separate documentation.
AliasesEpithalon, Epitalon, Ala-Glu-Asp-Gly
Evidence stagePublished cell-culture work provides a mechanistic basis for further study. It does not establish extended human lifespan, cancer prevention, or an anti-aging treatment.
U.S. regulatory contextThe sources linked here do not establish a broadly approved human anti-aging indication. Regulatory assessment and evidence of clinical benefit are separate questions.
CLINICAL REGISTRY

Selected registered research

No matching intervention record was found in ClinicalTrials.gov during this verification. This does not mean that no research exists.

INDEXED LITERATURE

Selected PubMed records

PMID 129376822003 Jun · Bulletin of experimental biology and medicine

Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells.

PMID 409084292025 Sep 4 · Biogerontology

Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity.

PMID 414902002026 Jan 1 · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

How to interpret this profile

Registry and publication counts describe discoverable records, not proof of effectiveness or safety. Study design, compound identity, population, endpoints, and regulatory context must be reviewed individually.

Primary sources: ClinicalTrials.gov (defined search) · PubMed (defined query)Checked October 7, 2026. Counts include interventional registry records with an explicit matching intervention name or alias; broad search results, biomarker-only observations, and unrelated compounds are excluded. Active includes recruiting, not yet recruiting, active not recruiting, and enrolling by invitation. PubMed is the linked title/abstract query count, not a number of clinical trials or a measure of evidence quality.

Displayed records are selected for relevance and recency; the page does not reproduce the complete source databases.

START HERE

Essential Epithalon guides

EPITHALON KNOWLEDGE ARTICLESPage 1 of 8
04
KNOWLEDGE ARTICLE

Epithalon Endogenic: What It Is and How It Works

Epithalon endogenic is a term that confuses many. Learn what epithalon is, whether it's naturally produced, and what research says about this peptide.

↗
07
KNOWLEDGE ARTICLE

Epitalon Peptide and Cancer: What Research Shows

Epitalon peptide cancer research is debated: telomerase activation may support tumors, yet lab studies show mixed results. Here's what the evidence says.

↗
08
KNOWLEDGE ARTICLE

How Long to Take Epitalon: Cycle Length Guide

How long to take Epitalon depends on the protocol, but most research cycles last 10 to 20 days. Learn typical schedules, dosing ranges, and safety.

↗
10
KNOWLEDGE ARTICLE

Thymalin Epitalon: Benefits, Dosage, and Safety

Thymalin epitalon is a peptide combo researched for immune support and longevity. Learn about benefits, dosage, safety, and what the science says.

↗
11
KNOWLEDGE ARTICLE

Epithalon Reviews: What Users and Research Say

Epithalon reviews from Reddit and research: what the peptide is, reported benefits, dosing, safety, and why it is not FDA-approved for human use.

↗
14
KNOWLEDGE ARTICLE

Epitalon for Sale: What to Know Before You Buy

Looking for epitalon for sale? Learn what this research peptide is, how to verify vendor quality, and key legal and safety considerations before buying.

↗
16
KNOWLEDGE ARTICLE

Epitalon Biowell: What Buyers Should Know

Epitalon Biowell is sold as a research-grade peptide, not an approved drug. See what the label, testing, dosing, and legal status mean for US buyers.

↗